ArticleBritish journal of cancer2024
MET exon 14 skipping mutation drives cancer progression and recurrence via activation of SMAD2 signalling.
Qiaoyan Liang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it